Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus

Conditions:   Multiple Sclerosis;   Pathologic Processes;   Demyelinating Diseases;   Demyelinating Autoimmune Diseases;   Nervous System Diseases;   Autoimmune Diseases;   Immune System Diseases;   Primary Progressive Multiple Sclerosis;   Relapsing Remitting Multiple Sclerosis Intervention:   Drug: Ocrelizumab Sponsors:   University of South Florida;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials